Related Experiment Video
Updated: Oct 26, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Outcomes of very preterm infants with neonatal hyperglycaemia: a systematic review and meta-analysis
Chandra Prakash Rath1,2, Madhusudhan Shivamallappa1,2, Saravanan Muthusamy1,2
1Neonatology, King Edward Memorial Hospital for Women, Subiaco, Western Australia, Australia.
Insights
Hyperglycaemia in very preterm infants is linked to increased mortality and severe complications like intraventricular hemorrhage and retinopathy of prematurity. Longer duration of high blood sugar worsens these adverse outcomes.
Area of Science:
- Neonatal Medicine
- Endocrinology
- Perinatal Epidemiology
Background:
- Hyperglycaemia is a common metabolic disturbance in very preterm infants.
- The association between hyperglycaemia and adverse outcomes in this vulnerable population requires further clarification.
Purpose of the Study:
- To systematically review and meta-analyze the association between hyperglycaemia and adverse outcomes in very preterm infants (<32 weeks or <1500 g).
Main Methods:
- Systematic review and meta-analysis of 46 studies including 34,527 infants.
- Data pooled using random-effects models for adjusted and unadjusted odds ratios (ORs).
- Subgroup analysis conducted based on study design (cohort and case-control).
Main Results:
- Unadjusted analysis indicated significant associations between hyperglycaemia and mortality, intraventricular haemorrhage (IVH), retinopathy of prematurity (ROP), sepsis, chronic lung disease, and disability.
- Adjusted analysis revealed significant associations only for mortality (aOR 2.37), any-grade IVH (aOR 2.60), and any-stage ROP (aOR 3.70).
- Higher glucose levels (>10 mmol/L) and longer duration of hyperglycaemia were associated with increased odds of mortality and adverse outcomes, respectively. GRADE of evidence was 'Low' or 'Very low'.
Conclusions:
- Hyperglycaemia in very preterm infants is associated with increased odds of mortality, any-grade IVH, and any-stage ROP.
- The lack of adjusted ORs in many studies limits definitive conclusions.
- Further research with robust adjusted analyses is warranted.
Objective:
To explore the association between hyperglycaemia and adverse outcomes in very preterm infants.
Design:
Systematic review and meta-analysis. Data were pooled separately for adjusted and unadjusted odds ratios (ORs) using random-effects model. Subgroup analysis was conducted based on study design (cohort and case control).
Main Outcome Measures:
Association between hyperglycaemia in preterm neonates (<32 weeks or <1500 g) and mortality and morbidities.
Findings:
Forty-six studies (30 cohort and 16 case control) with data from 34 527 infants were included. Meta-analysis of unadjusted ORs from cohort studies found hyperglycaemia to be significantly associated with mortality, any-grade intraventricular haemorrhage (IVH), severe IVH, any-stage retinopathy of prematurity (ROP), severe ROP, sepsis, chronic lung disease and disability. However, pooling of adjusted ORs found significant associations only for mortality (adjusted OR (CI): 2.37 (1.40 to 4.01); I2: 36%; 6 studies), 'Any grade IVH' (adjusted OR (CI): 2.60 (1.09 to 6.20); I2: 0%; 2 studies) and 'Any stage ROP' (adjusted OR (CI): 3.70 (1.55 to 8.84); I2: 0%; 2 studies). Meta-regression analysis found glucose levels >10 mmol/L to be associated with increased odds of mortality compared with <10 mmol/L. Pooled analysis from case-control studies were similar to cohort studies for most outcomes but limited by small sample size. Longer duration of hyperglycaemia was associated with adverse outcomes. GRADE of evidence was 'Low' or 'Very low'.
Conclusion:
Hyperglycaemia in very preterm infants is associated with higher odds of mortality, any-grade IVH and any-stage ROP. A limitation was lack of availability of adjusted ORs from many of the included studies.
Prospero Registration Number:
CRD42020193016.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Diabetes: Symptoms, Diagnosis, and Complications

